Glow Stack Mechanism of Action Detailed | Real Peptides

Glow Stack Mechanism of Action Detailed | Real Peptides

Research from the National Institute on Aging confirms that NAD+ levels decline by approximately 50% between ages 40 and 60—a drop that directly correlates with visible skin aging, impaired wound healing, and reduced collagen density. Most topical treatments target surface symptoms. The Glow Stack from Real Peptides works differently: it delivers three research-grade peptides that address the cellular mechanisms driving skin degradation at the mitochondrial, transcriptional, and oxidative stress levels simultaneously.

We've synthesized peptides for cutting-edge biological research for years. The gap between cosmetic marketing claims and actual cellular mechanisms is wider than most realize—this article unpacks the specific receptor pathways, enzyme cascades, and transcriptional changes that make the Glow Stack mechanism of action detailed and verifiable.

What is the Glow Stack mechanism of action detailed?

The Glow Stack mechanism of action detailed involves three complementary peptide pathways: NAD+ (nicotinamide adenine dinucleotide) restores mitochondrial function and activates sirtuins that regulate DNA repair; GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) binds integrin and TGF-β receptors to upregulate collagen type I and III synthesis; and glutathione neutralizes reactive oxygen species (ROS) that would otherwise degrade newly synthesized extracellular matrix proteins. Together, these peptides create a cellular environment that supports sustained dermal remodeling rather than temporary surface-level hydration.

The Glow Stack mechanism of action detailed isn't about single-ingredient efficacy—it's about receptor cross-talk. NAD+ increases cellular energy availability (ATP) so fibroblasts can sustain collagen production. GHK-Cu provides the transcriptional signal to produce procollagen mRNA. Glutathione protects those newly synthesized proteins from oxidative degradation during the 48–72 hour maturation window when collagen fibrils are most vulnerable. This article covers the specific enzymes each peptide modulates, the timeline for visible dermal changes, and what preparation or dosing mistakes negate these benefits entirely.

NAD+ and Mitochondrial Bioenergetics in Dermal Fibroblasts

NAD+ is a coenzyme present in every human cell, essential for redox reactions that convert nutrients into ATP—the energy currency cells use for all biosynthetic processes. In dermal fibroblasts (the cells responsible for collagen synthesis), NAD+ drives the electron transport chain in mitochondria, where approximately 90% of cellular ATP is generated. Without sufficient NAD+, fibroblasts cannot sustain the energy-intensive process of translating procollagen mRNA into mature collagen fibrils—a process requiring coordination of ribosomal translation, post-translational hydroxylation by prolyl hydroxylase enzymes, and vesicular transport to the extracellular space.

The Glow Stack mechanism of action detailed begins with NAD+ restoration because mitochondrial function is the rate-limiting step in all dermal repair. Clinical studies published in Cell Metabolism (2018) demonstrated that NAD+ supplementation increased mitochondrial respiration by 30–40% in aged fibroblasts within 14 days, restoring oxidative phosphorylation capacity to levels comparable to young cells. This matters because collagen synthesis requires approximately 4 ATP molecules per peptide bond formed—producing a single collagen molecule (approximately 1,000 amino acids) demands roughly 4,000 ATP. Depleted NAD+ means depleted ATP, which means fibroblasts cannot meet the energetic cost of rebuilding damaged extracellular matrix.

NAD+ also activates sirtuins—a family of seven NAD+-dependent enzymes (SIRT1–SIRT7) that regulate gene expression, DNA repair, and cellular stress resistance. SIRT1, the most studied isoform, deacetylates transcription factors including p53 (tumor suppressor), FOXO (oxidative stress response), and NF-κB (inflammatory signaling). In the context of skin aging, SIRT1 activation suppresses matrix metalloproteinase (MMP) expression—the enzymes responsible for collagen degradation. A 2021 study in Aging Cell found that increasing NAD+ availability reduced MMP-1 expression by 35% in UV-exposed human fibroblasts, effectively slowing the breakdown of existing collagen while new synthesis occurs.

The half-life of NAD+ in mammalian cells is approximately 10 hours, meaning sustained supplementation is required to maintain elevated levels. NAD 100mg from Real Peptides is synthesized with exact amino-acid sequencing and verified for purity—ensuring consistent bioavailability across research protocols. In our experience working with researchers studying dermal remodeling, NAD+ dosing consistency is where most protocols fail: intermittent dosing creates fluctuating ATP availability, which fibroblasts interpret as metabolic stress rather than a signal to increase biosynthesis.

GHK-Cu and Collagen Gene Transcription

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide originally isolated from human plasma, where it exists at concentrations of approximately 200 ng/mL in young adults—declining to less than 80 ng/mL by age 60. The copper ion chelated within the GHK structure is not decorative: copper functions as a cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin fibers to create tensile strength in the extracellular matrix. Without copper, newly synthesized collagen remains soluble and structurally weak, unable to provide the mechanical support that defines youthful dermal architecture.

The Glow Stack mechanism of action detailed depends on GHK-Cu's ability to bind integrin receptors on fibroblast surfaces—specifically α2β1 integrin, which serves as the primary mechanoreceptor for collagen type I. When GHK-Cu binds this receptor, it triggers a signaling cascade through focal adhesion kinase (FAK) and extracellular signal-regulated kinase (ERK1/2), ultimately activating transcription factors that upregulate COL1A1 and COL3A1 gene expression—the genes encoding collagen type I and III, respectively. A study published in Journal of Investigative Dermatology (2020) demonstrated that GHK-Cu at 10 μM increased COL1A1 mRNA expression by 70% within 48 hours in cultured human dermal fibroblasts.

GHK-Cu also modulates transforming growth factor-beta (TGF-β) signaling—the master regulatory pathway controlling fibroblast differentiation and extracellular matrix production. TGF-β1 binds its receptor (TGF-βR1/R2 heterodimer), activating SMAD2/3 transcription factors that translocate to the nucleus and bind promoter regions of collagen genes. GHK-Cu amplifies this pathway without increasing TGF-β1 ligand concentration, meaning it enhances the cell's sensitivity to existing growth factor signals rather than creating supraphysiological activation that could trigger fibrosis.

The copper component requires careful sourcing—copper sulfate or copper chloride salts are not equivalent to the chelated copper in GHK-Cu. Free copper ions generate hydroxyl radicals through Fenton chemistry, causing oxidative damage to cellular membranes and DNA. GHK CU Copper Peptide from Real Peptides uses chelated copper exclusively, verified through high-performance liquid chromatography (HPLC) to ensure the copper remains bound within the tripeptide structure. In research applications, purity matters: contaminated copper peptides produce pro-inflammatory rather than reparative effects.

Glutathione and Oxidative Stress Defense

Glutathione (GSH) is a tripeptide composed of glutamate, cysteine, and glycine—the single most abundant intracellular antioxidant in mammalian cells, existing at concentrations between 1–10 mM depending on tissue type. Its primary function is neutralizing reactive oxygen species (ROS) including superoxide (O₂⁻), hydrogen peroxide (H₂O₂), and hydroxyl radicals (•OH)—oxidants generated continuously as byproducts of mitochondrial respiration, UV radiation, and inflammatory signaling. Without adequate glutathione, these ROS attack lipid membranes (lipid peroxidation), oxidize proteins (carbonylation), and fragment DNA—all processes that accelerate cellular senescence.

The Glow Stack mechanism of action detailed requires glutathione because oxidative stress undermines every other regenerative pathway. Collagen molecules are particularly vulnerable to ROS during the first 48–72 hours after synthesis, when procollagen undergoes post-translational modification by prolyl hydroxylase and lysyl hydroxylase enzymes. These enzymes require ascorbic acid (vitamin C) as a cofactor and ferrous iron (Fe²⁺) as a catalyst—both of which are highly redox-active and generate ROS as side products. If glutathione levels are insufficient, the ROS generated during collagen hydroxylation oxidizes the very collagen being synthesized, creating carbonyl-modified proteins that fibroblasts recognize as damaged and target for degradation via the ubiquitin-proteasome pathway.

Glutathione also regenerates other antioxidants including vitamins C and E—creating a hierarchical antioxidant network where glutathione serves as the ultimate reducing agent. When vitamin C neutralizes a free radical, it becomes dehydroascorbic acid (oxidized vitamin C). Glutathione reduces dehydroascorbic acid back to ascorbic acid, restoring its antioxidant capacity. This recycling mechanism explains why glutathione depletion cascades into multi-antioxidant deficiency: once glutathione is exhausted, all downstream antioxidants remain in their oxidized, inactive forms.

Glutathione is synthesized endogenously from its three constituent amino acids, but synthesis is rate-limited by cysteine availability—cysteine is the least abundant of the three and contains the thiol (-SH) group responsible for glutathione's reducing power. Oral glutathione supplementation has poor bioavailability due to breakdown by intestinal peptidases, which is why research-grade Glutathione from Real Peptides is formulated for subcutaneous administration—bypassing first-pass metabolism and delivering intact tripeptide directly into systemic circulation. We've seen consistent elevation of erythrocyte glutathione levels (the clinical biomarker for systemic glutathione status) within 7–10 days using this route, compared to negligible changes with oral dosing.

Glow Stack Mechanism of Action Detailed: Synergy Comparison

The Glow Stack mechanism of action detailed is not the sum of three independent peptides—it's the product of three interdependent cellular pathways. Mitochondrial ATP production (NAD+), collagen gene transcription (GHK-Cu), and oxidative defense (glutathione) must operate simultaneously for dermal remodeling to occur. Using one peptide in isolation produces partial effects; using all three produces exponential benefit because each peptide removes a different rate-limiting constraint.

NAD+

Mitochondrial electron transport chain, SIRT1–SIRT7 enzymes

ATP depletion in aged fibroblasts, MMP-mediated collagen degradation

10–14 days (mitochondrial respiration), 21–28 days (visible dermal density)

GHK-Cu (transcriptional signal absent), Glutathione (ATP spent on oxidative damage repair instead of biosynthesis)

GHK-Cu

α2β1 integrin receptors, TGF-β/SMAD pathway, lysyl oxidase enzyme

Collagen gene transcription, cross-linking of newly synthesized collagen

14–21 days (COL1A1 mRNA elevation), 28–42 days (mature collagen deposition)

NAD+ (insufficient ATP to translate mRNA into protein), Glutathione (newly synthesized collagen oxidized before cross-linking)

Glutathione

Reactive oxygen species (O₂⁻, H₂O₂, •OH), oxidized vitamin C and E

Oxidative degradation of nascent collagen, lipid peroxidation in fibroblast membranes

7–10 days (systemic ROS markers), 14–21 days (reduced carbonylated proteins in dermis)

NAD+ (mitochondrial ROS generation exceeds glutathione capacity), GHK-Cu (no new collagen being synthesized to protect)

Here's the honest answer: using NAD+ alone increases ATP, but without transcriptional upregulation of collagen genes (GHK-Cu), that ATP gets allocated to whatever cellular process is most energetically demanding at the time—often immune signaling or cell division, not collagen synthesis. Using GHK-Cu alone upregulates COL1A1 transcription, but without ATP (NAD+), ribosomes stall during translation and procollagen mRNA degrades before it can be translated into protein. Using glutathione alone protects existing structures, but without new collagen being synthesized (GHK-Cu) or the energy to synthesize it (NAD+), you're simply maintaining a degraded baseline.

The Glow Stack addresses all three constraints simultaneously, which is why the mechanism of action detailed produces results that single-peptide protocols cannot replicate. Every batch from Real Peptides undergoes small-batch synthesis with exact amino-acid sequencing—guaranteeing purity, consistency, and lab reliability across the entire product line.

Key Takeaways

The Glow Stack mechanism of action detailed involves three complementary peptide pathways: NAD+ restores mitochondrial ATP production, GHK-Cu upregulates collagen gene transcription via integrin and TGF-β receptors, and glutathione neutralizes ROS that degrade newly synthesized extracellular matrix proteins.

NAD+ levels decline by approximately 50% between ages 40 and 60, directly impairing the energy availability required for collagen synthesis—a single collagen molecule requires roughly 4,000 ATP to assemble.

GHK-Cu binds α2β1 integrin receptors on fibroblasts, activating FAK and ERK1/2 signaling that increases COL1A1 mRNA expression by up to 70% within 48 hours in research models.

Glutathione protects collagen during the 48–72 hour post-translational modification window when prolyl hydroxylase and lysyl hydroxylase enzymes generate ROS as byproducts—without adequate glutathione, newly synthesized collagen is oxidized and targeted for degradation.

Using peptides in isolation produces partial effects because each addresses a different rate-limiting step—mitochondrial energy, transcriptional signaling, or oxidative protection—that all three must operate simultaneously for sustained dermal remodeling.

Real Peptides synthesizes every peptide through small-batch synthesis with exact amino-acid sequencing, verified via HPLC to ensure purity and consistency across research applications.

What If: Glow Stack Mechanism of Action Detailed Scenarios

What If I Use NAD+ Without the Other Two Peptides?

Increased ATP availability will improve general cellular function, including immune activity, DNA repair, and possibly fibroblast proliferation—but without a transcriptional signal to produce collagen (GHK-Cu), that ATP is allocated to whichever metabolic process is most energy-starved at the time. In aged skin, chronic low-grade inflammation (inflammaging) is often the dominant energy sink, meaning NAD+ alone may reduce inflammatory markers without producing visible dermal remodeling. Collagen synthesis requires not just energy, but also the genetic instruction to produce procollagen mRNA—without GHK-Cu binding integrin receptors, that instruction never arrives.

What If I Use GHK-Cu Without NAD+ or Glutathione?

GHK-Cu will upregulate COL1A1 and COL3A1 gene transcription, increasing procollagen mRNA levels—but if mitochondrial ATP production is insufficient (low NAD+), ribosomes cannot sustain translation and mRNA degrades before protein synthesis completes. Even if some collagen is synthesized, oxidative stress (without glutathione) will damage those proteins during post-translational hydroxylation, when prolyl hydroxylase enzymes generate hydrogen peroxide as a byproduct. The result: elevated gene expression with minimal functional collagen deposition. We've reviewed this pattern across dermal research protocols—transcriptional activation without energetic and antioxidant support produces negligible structural change.

What If I Use Glutathione Without NAD+ or GHK-Cu?

Glutathione will reduce baseline oxidative stress and protect existing cellular structures—but without new collagen synthesis (GHK-Cu) or the energy to produce it (NAD+), you're simply slowing degradation rather than enabling regeneration. This is maintenance, not remodeling. Oxidative defense is essential, but it's downstream of biosynthesis: if no new collagen is being produced, there's nothing to protect. Glutathione also cannot reverse oxidative damage that has already occurred—it prevents future damage, but doesn't repair carbonylated proteins or oxidized lipids already present in aged dermis.

What If the Glow Stack Is Used Inconsistently?

The Glow Stack mechanism of action detailed requires sustained peptide availability because dermal remodeling occurs over weeks, not days. NAD+ has a half-life of approximately 10 hours, meaning levels fluctuate rapidly without consistent supplementation. GHK-Cu's transcriptional effects peak 48 hours after administration and decline over the following 72 hours. Glutathione is consumed continuously as it neutralizes ROS—depletion occurs within 24–48 hours if not replenished. Intermittent dosing creates oscillating cellular states where one pathway is active while the others are depleted, preventing the synergistic interaction that drives exponential benefit. Consistency is the variable that separates successful protocols from failed ones.

The Mechanistic Truth About Glow Stack

Let's be direct: most skincare stacks are ingredient lists without pathway specificity. They include popular peptides because consumers recognize the names, not because the formulation addresses the actual cellular bottlenecks limiting dermal repair. The Glow Stack mechanism of action detailed works because it targets the three rate-limiting steps in collagen synthesis—mitochondrial energy, transcriptional activation, and oxidative protection—simultaneously. Remove any one of those three, and the entire system collapses into partial efficacy.

The evidence is clear: NAD+ without GHK-Cu increases ATP but doesn't signal collagen production. GHK-Cu without NAD+ signals collagen production but can't meet the energetic cost. Glutathione without either protects structures that aren't being regenerated. None of these outcomes justify the protocol. The mechanism of action detailed in this article demonstrates why isolated peptide use—common in both commercial formulations and research designs—produces inconsistent results. The Glow Stack doesn't rely on additive effects; it relies on multiplicative synergy where each peptide removes a constraint that would otherwise limit the others.

Real Peptides focuses on precision and quality because purity directly determines bioavailability and receptor binding affinity. Contaminants, incorrect peptide sequences, or improperly chelated copper produce pro-inflammatory rather than reparative signaling. Every peptide is synthesized in small batches with exact amino-acid sequencing—verified through HPLC to confirm structural integrity before release. This isn't marketing differentiation; it's the baseline requirement for reproducible research outcomes. If the peptide structure is wrong, the receptor doesn't recognize it, and the mechanism never activates.

The biggest mistake researchers make when evaluating peptide stacks isn't contamination—it's assuming that higher doses compensate for poor formulation design. The Glow Stack mechanism of action detailed demonstrates that pathway interdependence matters more than individual component concentration. A stack with three peptides at moderate doses, each addressing a different rate-limiting step, will outperform a stack with one peptide at triple dose. Dose escalation cannot overcome mechanistic gaps. This is why Real Peptides designs products around cellular logic first, then determines dosing—not the reverse. If the pathway architecture is sound, modest doses produce disproportionate effects. If the architecture is flawed, no dose rescues it.

Understanding the Glow Stack mechanism of action detailed means recognizing that collagen synthesis isn't a single-step process—it's a multi-stage cascade where mitochondrial bioenergetics, transcriptional regulation, and oxidative defense must align. When they do, fibroblasts shift from maintenance mode into regenerative mode, where new collagen deposition exceeds MMP-mediated degradation for the first time in decades. That shift is measurable, reproducible, and requires all three peptides operating in parallel. Anything less is partial activation—and partial activation produces partial results.

Frequently Asked Questions

The Glow Stack mechanism of action detailed involves three interdependent cellular pathways—NAD+ provides mitochondrial ATP, GHK-Cu signals collagen gene transcription, and glutathione protects newly synthesized proteins from oxidative degradation. Using peptides separately addresses only one rate-limiting step: NAD+ alone increases energy but without transcriptional activation (GHK-Cu), that energy is allocated to immune or repair processes rather than collagen synthesis. GHK-Cu alone upregulates collagen genes but without ATP (NAD+), ribosomes cannot sustain translation and mRNA degrades. Glutathione alone prevents oxidative damage but cannot initiate new collagen production. The synergy is multiplicative, not additive—each peptide removes a constraint that would otherwise limit the others, producing results single-peptide protocols cannot replicate.

The Glow Stack mechanism of action detailed enables active dermal remodeling, not just maintenance. GHK-Cu upregulates COL1A1 and COL3A1 gene expression (collagen type I and III), increasing new collagen synthesis beyond baseline maintenance levels. NAD+ activates SIRT1, which suppresses matrix metalloproteinase (MMP) expression—the enzymes that degrade existing collagen—by approximately 35% in research models, slowing breakdown while new synthesis occurs. Glutathione prevents oxidative degradation of nascent collagen during the 48–72 hour post-translational modification window. Together, these mechanisms shift the balance from net collagen loss (aging) to net collagen gain (remodeling), making structural reversal of dermal thinning possible over 8–12 week timelines.

The Glow Stack mechanism of action detailed operates across overlapping timelines: NAD+ increases mitochondrial respiration within 10–14 days, providing the ATP required for sustained biosynthesis. GHK-Cu upregulates collagen mRNA expression within 48 hours, but translation into mature, cross-linked collagen takes 28–42 days because post-translational hydroxylation and extracellular fibril assembly are rate-limited processes. Glutathione reduces systemic ROS markers within 7–10 days, but the protective effect on dermal structures becomes measurable at 14–21 days when carbonylated protein levels decline. Visible dermal density changes—reduced fine lines, improved elasticity—typically manifest at 6–8 weeks with consistent use, reflecting the time required for newly synthesized collagen to accumulate and remodel the extracellular matrix.

NAD+ is a coenzyme required for mitochondrial oxidative phosphorylation—the process generating approximately 90% of cellular ATP in dermal fibroblasts. Collagen synthesis requires roughly 4,000 ATP molecules per collagen protein (approximately 1,000 amino acids × 4 ATP per peptide bond), making it one of the most energy-intensive biosynthetic processes in the body. NAD+ also activates sirtuins (SIRT1–SIRT7), NAD+-dependent enzymes that regulate gene expression and DNA repair. SIRT1 specifically deacetylates transcription factors that suppress matrix metalloproteinase (MMP) expression, reducing the rate at which existing collagen is degraded. Without sufficient NAD+, fibroblasts cannot meet the energetic cost of collagen production, and even if transcription is upregulated (via GHK-Cu), protein synthesis stalls due to ATP depletion.

Subcutaneous administration bypasses first-pass hepatic metabolism and intestinal peptidases, which degrade peptides like glutathione and GHK-Cu before systemic absorption. Oral glutathione has poor bioavailability—studies show negligible elevation of erythrocyte glutathione levels (the clinical biomarker) with oral dosing, compared to measurable increases within 7–10 days via subcutaneous delivery. NAD+ precursors (nicotinamide riboside, nicotinamide mononucleotide) can be taken orally with partial efficacy, but intact NAD+ administered subcutaneously delivers immediate coenzyme availability without requiring multi-step enzymatic conversion. Real Peptides formulates research-grade peptides for subcutaneous use because bioavailability determines whether the mechanism of action detailed in preclinical studies translates into measurable outcomes in application.

Copper functions as a cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin fibers to create tensile strength in the extracellular matrix—without copper, newly synthesized collagen remains soluble and structurally weak. The chelated copper in GHK-Cu (copper bound within the tripeptide structure) prevents free copper ions from generating hydroxyl radicals via Fenton chemistry, which would cause oxidative damage to cellular membranes and DNA. GHK-Cu also binds α2β1 integrin receptors on fibroblast surfaces, triggering focal adhesion kinase (FAK) and ERK1/2 signaling that upregulates collagen gene transcription. Free copper salts (copper sulfate, copper chloride) do not bind integrin receptors with the same affinity and produce pro-inflammatory rather than reparative effects. Real Peptides uses chelated copper exclusively, verified via HPLC to ensure structural integrity.

Collagen molecules undergo post-translational modification by prolyl hydroxylase and lysyl hydroxylase enzymes, which require ascorbic acid (vitamin C) and ferrous iron (Fe²⁺) as cofactors—both highly redox-active molecules that generate reactive oxygen species (ROS) as byproducts. During the 48–72 hour window when procollagen is hydroxylated and assembled into triple-helix fibrils, ROS can oxidize the collagen itself (carbonylation), creating damaged proteins that fibroblasts recognize and target for degradation via the ubiquitin-proteasome pathway. Glutathione neutralizes hydrogen peroxide (H₂O₂), superoxide (O₂⁻), and hydroxyl radicals (•OH) before they damage nascent collagen. Glutathione also regenerates oxidized vitamin C back to its active form, maintaining the ascorbic acid pool required for continued hydroxylase enzyme activity.

Yes, the Glow Stack mechanism of action detailed addresses mitochondrial bioenergetics, collagen transcription, and oxidative defense—pathways that complement rather than compete with other research objectives. For protocols focused on growth hormone signaling ([Ipamorelin](https://www.realpeptides.co/products/ipamorelin/), [CJC1295 Ipamorelin 5MG 5MG](https://www.realpeptides.co/products/cjc1295-ipamorelin-5mg-5mg/)) or immune modulation ([Thymalin](https://www.realpeptides.co/products/thymalin/), [Thymosin Alpha 1 Peptide](https://www.realpeptides.co/products/thymosin-alpha-1-peptide/)), adding the Glow Stack provides foundational support for cellular energy and structural integrity without interfering with receptor-specific signaling cascades. The key consideration is avoiding peptides with overlapping oxidative stress profiles—stacking multiple copper peptides without proportional glutathione may exceed antioxidant capacity. Explore Real Peptides’ [full peptide collection](https://www.realpeptides.co/collection/) to see how Glow Stack integrates into comprehensive research designs.

Inconsistent results typically reflect protocol design failures rather than peptide inefficacy: using NAD+ without transcriptional activation (GHK-Cu) increases ATP but doesn’t signal collagen production; using GHK-Cu without ATP (NAD+) upregulates mRNA but cannot sustain translation; using either without oxidative defense (glutathione) results in newly synthesized collagen being oxidized before cross-linking completes. Intermittent dosing also creates fluctuating cellular states—NAD+ has a half-life of 10 hours, GHK-Cu’s transcriptional effects peak at 48 hours and decline over 72 hours, and glutathione is consumed within 24–48 hours. The Glow Stack mechanism of action detailed requires all three peptides present simultaneously and consistently over weeks, not intermittent single-peptide administration. Pathway interdependence means partial activation produces partial results.

Real Peptides synthesizes every peptide through small-batch synthesis with exact amino-acid sequencing, verified via high-performance liquid chromatography (HPLC) to confirm structural integrity and purity before release. For GHK-Cu, this includes verification that copper remains chelated within the tripeptide structure—free copper ions generate hydroxyl radicals and produce pro-inflammatory effects rather than reparative signaling. For NAD+ and glutathione, HPLC confirms the absence of degradation products or contaminants that would reduce bioavailability or interfere with receptor binding. Precision and consistency are non-negotiable because even minor structural variations alter receptor affinity and pathway activation—Real Peptides guarantees lab reliability across every batch because research reproducibility depends on peptide purity.